MedPath

The use of intravesical lignocaine to reduce pain and increase dwell time of intravesical mitomycin chemotherapy

Not Applicable
Completed
Conditions
Analgesia for intravesical mitomycin chemotheapy
Cancer
Malignant neoplasm of bladder
Registration Number
ISRCTN65454120
Lead Sponsor
Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with transitional cell carcinoma of the bladder, following their first endoscopic resection.

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual analogue pain scores. Dwell time.
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath